Yuxiang Ma

1.5k citations
32 papers · 1.3k indexed · 1 hit paper · h-index 16
Topics
Nanoplatforms for cancer theranostics (10 papers)Nanoparticle-Based Drug Delivery (5 papers)Nanocluster Synthesis and Applications (4 papers)
Partner nations
ChinaUnited States

In The Last Decade

Yuxiang Ma

31 papers receiving 1.3k citations

Hit Papers

In Vivo Targeted Deep-Tissue Photodynamic Therapy Based o...20122026201620212012100200300400

Peers

Yuxiang Ma
Comparison fields: 5 of 104
  • Biomedical Engineering 574
  • Materials Chemistry 512
  • Molecular Biology 382
  • Pulmonary and Respiratory Medicine 231
  • Biomaterials 186
Replace Abbas Salihi with:
Abbas Salihi Iraq
Hang Zhang China
Longguang Tang China
Pavan P. Adiseshaiah United States
Tingting Chen China
Yun Zhao China
Hao Cheng China
Chen Fu China
Junzhu Wu China
Hideki Ohba Japan
Yuxiang Ma relative to Abbas Salihi Iraq Abbas Salihi's profile →
Citations per field
00.5×50×107×
Abbas Salihi · 1×
Citations per year

Countries citing papers authored by Yuxiang Ma

Since Specialization
Citations

This map shows the geographic impact of Yuxiang Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuxiang Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuxiang Ma more than expected).

Fields of papers citing papers by Yuxiang Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuxiang Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuxiang Ma. The network helps show where Yuxiang Ma may publish in the future.

Co-authorship network of co-authors of Yuxiang Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Yuxiang Ma. A scholar is included among the top collaborators of Yuxiang Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuxiang Ma. Yuxiang Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 11
3 3
4 0
5 2
6 16
7 26
8 18
9 8
10 43
11 11
12 10
13 12
14 32
15 23
16 26
17 94
18 23
19 183
20 2

About Yuxiang Ma

Yuxiang Ma is a scholar working on Biomaterials, Biomedical Engineering and Biotechnology, having authored 32 papers that have together received 1.3k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (10 papers), Nanoparticle-Based Drug Delivery (5 papers) and Nanocluster Synthesis and Applications (4 papers). The work is most often cited by research in Biomaterials (186 citations), Biomedical Engineering (574 citations) and Materials Chemistry (512 citations). Yuxiang Ma has collaborated with scholars based in China and United States. Frequent co-authors include Yueqing Gu, Sisi Cui, Samuel Achilefu, Yuqi Chen, Haiyan Chen, Haiyan Chen, Suozhu Shi, Xiangmei Chen, Rui Ding and Xueyuan Bai. Their work appears in journals such as ACS Nano, Biomaterials and Food Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026